Literature DB >> 12848600

[Appropriateness of the admissions and stays in an internal medicine department of a secondary hospital using the current version of the AEP ( Appropriateness Evaluation Protocol)].

F J Rodríguez-Vera1, Y Marín Fernández, A Sánchez, C Borrachero, E Puyol de la Llave.   

Abstract

AIMS: To Study the inappropriateness of the admissions and stays in an Internal Medicine Department using the concurrent version of the AEP (Appropriateness Evaluation Protocol).
METHOD: Aplication of the concurrent version of the AEP to all the patients internated in an Internal Medicine Department. 257
RESULTS: 59 patients and 485 stays fulfilled the inclusion criteria. A 15.3/ of the admissions and a 33/ of the stays did not acomplish the criteria of appropriateness of the AEP. The most frequent cause of innappropriate admision was to avoid the delay of the ambulatory studies. The most common cause of innappropriate stay was the wait for results of complementary tests and consultancy between different specialities.
CONCLUSIONS: Using the concurrent version of the AEP allows to obtain information about the overuse of the hospitalization resources in an easy and rapid way. The results obtained in our study are similar to other made in Spain using the retrospective version of the AEP.

Entities:  

Mesh:

Year:  2003        PMID: 12848600

Source DB:  PubMed          Journal:  An Med Interna        ISSN: 0212-7199


  2 in total

1.  Reduction in inappropriate hospital use based on analysis of the causes.

Authors:  Víctor Soria-Aledo; Andrés Carrillo-Alcaraz; Benito Flores-Pastor; Alfredo Moreno-Egea; Milagros Carrasco-Prats; José Luis Aguayo-Albasini
Journal:  BMC Health Serv Res       Date:  2012-10-17       Impact factor: 2.655

2.  Morbidity diagnosed in an internal medicine department of a secondary care center (Msaken, Sousse, Tunisia).

Authors:  Mohamed Khelil; Chokri Zoghlami; Imen Horrigue; Dhekra Chebil; Sarra Nouira; Abdelhamid Ben Lakhal; Ahmed Ben Abdelaziz
Journal:  Tunis Med       Date:  2021-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.